| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 38.61  |
1-year : | 45.1 |
| Resists | First : | 33.06 |
Second : | 38.61 |
| Pivot price | 23.31 |
|||
| Supports | First : | 24.59 |
Second : | 19.36 |
| MAs | MA(5) : | 26.51 |
MA(20) : | 22.73 |
| MA(100) : | 18.81 |
MA(250) : | 17.79 |
|
| MACD | MACD : | 1.5 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 80.4  |
D(3) : | 85.3 |
| RSI | RSI(14): 79.7 |
|||
| 52-week | High : | 33.06 | Low : | 12.8 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VTVT ] has closed It is unclear right now based on current values. 181.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 29.59 - 29.7 | 29.7 - 29.81 |
| Low: | 25 - 25.12 | 25.12 - 25.24 |
| Close: | 27.78 - 27.98 | 27.98 - 28.18 |
Tue, 11 Nov 2025
All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy - sharewise.com
Tue, 11 Nov 2025
How to use a screener to detect VTVT breakouts - M&A Rumor & Risk Managed Investment Entry Signals - newser.com
Mon, 10 Nov 2025
Why VTVT stock is rated strong buy - Trade Exit Report & Safe Capital Growth Plans - newser.com
Mon, 10 Nov 2025
Q1 Earnings Estimate for VTVT Issued By HC Wainwright - MarketBeat
Sun, 09 Nov 2025
What to expect from VTVT in the next 30 days - Trade Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
Fri, 07 Nov 2025
vTv Therapeutics (NASDAQ:VTVT) Releases Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 1.52e+006 (%) |
| Held by Institutions | 35.5 (%) |
| Shares Short | 17 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.557e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -150 % |
| Return on Assets (ttm) | 717.6 % |
| Return on Equity (ttm) | -44 % |
| Qtrly Rev. Growth | 17000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -312 |
| EBITDA (p.s.) | -1.75821e+007 |
| Qtrly Earnings Growth | -3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.1 |
| Price to Cash Flow | 46.06 |
| Dividend | 0 |
| Forward Dividend | 22810 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|